Evidence map›Paper›PMID 41021619›Full record

ArticlePLOS global public health2025

Opportunities and barriers arising from the COVID-19 pandemic for health campaign integration across immunizations, neglected tropical diseases, insecticide-treated bed nets, and vitamin A supplementation: A qualitative key informant interview study.

Alison Krentel, Afzaa Rajabali, Olumide Ogundahunsi, Tuoyo Okorosobo, Eva Bazant, Carol McPhillips-Tangum, Aashka Sethi Sood, Kristin Saarlas, Margaret Gyapong

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alison KrentelSchool of Epidemiology and Public Health, University of Ottawa, Canada.ORCID https://orcid.org/0000-0001-7213-1577
Afzaa RajabaliBruyère Health Research Institute, Ottawa, Canada.
Olumide OgundahunsiUniversity of Medical Sciences, Ondo, Nigeria.ORCID https://orcid.org/0000-0002-9192-0886
Tuoyo OkorosoboUniversity of Medical Sciences, Ondo, Nigeria.
Eva BazantHealth Campaign Effectiveness Coalition, The Task Force for Global Health, Decatur, Georgia, United States of America.
Carol McPhillips-TangumCMT Consulting, LLC, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-0390-0966
Aashka Sethi SoodBruyère Health Research Institute, Ottawa, Canada.
Kristin SaarlasHealth Campaign Effectiveness Coalition, The Task Force for Global Health, Decatur, Georgia, United States of America.ORCID https://orcid.org/0000-0001-9847-9280
Margaret GyapongCenter for Health Policy and Implementation Research, Institute of Health Research, University of Health and Allied Sciences, Ho, Volta Region, Ghana.ORCID https://orcid.org/0000-0002-4818-3497

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In low- and middle-income countries, health campaigns play a crucial role in addressing high-priority health concerns such as neglected tropical diseases (NTDs), malaria, vaccine-preventable diseases and nutrition (vitamin A supplementation). Many health campaigns are conducted throughout the calendar year, resulting in multiple campaigns annually in some communities. Campaign integration offers an opportunity to increase efficiencies across programs and limit the strain on healthcare workers, communities, and health systems. The response to the COVID-19 pandemic provided opportunities for campaign integration to mitigate losses from missed campaign deliveries. As the interest in integration grows, there is a need to understand existing barriers, bottlenecks, and opportunities for better integration, whether through co-delivery or increased collaboration. This qualitative study aimed to understand the opportunities and barriers to campaign co-delivery and collaboration from the perspective of 26 stakeholders involved in vaccine-preventable diseases, vitamin A supplementation, NTDs, and malaria programs. Key informants included campaign managers, implementing partners, donors, and decision-makers at the country and state levels in five countries: Côte d'Ivoire, Ethiopia, Guyana, Indonesia, and Nigeria. Results indicated that campaigns were integrated at various levels, from partial integration and co-delivery to fully integrated delivery within existing health services. Most emerging factors were categorized as either facilitating or hindering campaign integration. Enablers to campaign integration included joint planning and appreciation for human resources, while target population variation, prioritization of one intervention by another, and overburdening of healthcare workers, community health workers and community drug distributors were identified as specific barriers. An emerging theme was the importance of leadership, reinforcing the need for country ownership, political will, and positive stakeholder relationships. Further research is warranted to identify optimal combinations of campaign commodities, strategies to ensure stakeholder engagement throughout the integration process, methods to factor in local community context, and the expansion of lessons learned from the COVID-19 pandemic.

Identifiers

PMID41021619
PMCPMC12478929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.